查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1820419

2025 年至 2033 年放射治疗市场规模、份额、趋势及预测（按类型、应用、最终用户和地区）

Radiotherapy Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球放射治疗市场规模达71亿美元。展望未来， IMARC Group预测，到2033年，市场规模将达到99亿美元，2025-2033年期间的复合年增长率为3.8%。目前，北美占据市场主导地位，2024年的市占率将超过35.8%。市场成长的因素有很多，包括癌症发病率上升、技术快速进步、肿瘤靶向准确性提高、医疗成本上升以及人们对放射治疗作为一种非侵入性癌症治疗替代方案的优势的认识不断提高。

癌症发生率的上升是放射治疗市场的主要因素之一。癌症是全球日益增长的死亡原因，每年确诊的病例数百万。预计到 2024 年，美国将确诊约 2,001,140 例新发癌症病例，其中 611,720 人死于癌症。这种日益增长的负担增加了对放射治疗等更好治疗方案的需求。放射治疗是癌症治疗的关键组成部分，因为它可以精确地瞄准恶性细胞，同时将对健康组织的伤害降至最低。此外，老年人口的增长也加剧了这种需求，因为癌症风险随着年龄的增长而增加。除此之外，各国政府和医疗保健组织正在启动宣传计划和早期筛检计划，以便在可治疗阶段发现癌症，从而促进放射治疗的使用。

美国凭藉其快速的技术进步和政府在医疗保健方面的投入，成为市场颠覆者之一。非侵入性治疗方案的采用也使其脱颖而出。美国市场在尖端放射技术的实施方面处于领先地位，这极大地促进了市场的成长。近年来，质子治疗设施的数量和地理不断扩张，仅在美国就拥有超过40个营运中心，不仅提高了患者就诊的可及性，也显着提高了收集临床资料和参与多中心临床研究的能力。此外，美国不断增长的医疗保健支出（预计到2023年将成长7.5%，达到4.8兆美元）是该国放射治疗成长的关键驱动力。此外，像「癌症登月计画」这样的联邦计画致力于透过加强研究、创新和医疗服务可近性来降低癌症死亡率，这也推动了市场扩张。资金的增加促成了配备最先进放射治疗系统的专科癌症中心的建立。

放射治疗市场趋势：

技术进步

放射治疗产业的最新进展和技术，例如影像导引放射治疗 (IGRT) 和调强放射治疗 (IMRT)，提高了癌症治疗的准确性和有效性，从而促进了市场的成长。 IGRT 涉及使用即时成像，以确保即使在治疗期间有移动的情况下，放射治疗期间也能精确瞄准肿瘤。这使医生能够透过调整治疗期间的光束强度来调整辐射剂量，从而使辐射剂量与肿瘤形状相匹配，同时减少对邻近健康组织的照射。此外，国际原子能总署于 2020 年 4 月启动了一项研究，旨在调查立体定位分次放射治疗 (SFRT) 如何改善子宫颈和肺部恶性肿瘤的姑息治疗，以减轻症状并延缓病程，这有助于促进市场成长。居礼研究所拥有欧洲最全面的技术放射治疗平台，是法国领先的质子治疗中心。居礼研究所计划于2023年启动一项涵盖广泛的放射治疗项目，其中包括一项重大投资计划，旨在推动其技术平台的现代化，并为患者提供最具创新性和突破性的技术。这项重大计画将在6年内投资5,600万欧元（5,898万美元），涵盖所有放射治疗设备以及居礼研究所在巴黎、圣克卢和奥赛的所有分支机构。

人工智慧（AI）在放射治疗的应用

人工智慧技术正被用于简化计划流程、提高放射剂量的准确性并优化治疗方案。机器学习 (ML) 演算法可以分析海量影像和治疗记录资料集，从而识别模式并预测针对个别患者的最佳治疗方法。人工智慧也被用于开发患者对各种放射疗法反应的预测模型，该模型可用于自适应放射治疗，根据患者对持续治疗的反应调整治疗方案。放射科医生在 40 年内需要查看约 225,000 张 MRI/CT 检查结果，而人工智慧可以从 225,000 张扫描结果开始进行自我训练，并在很短的时间内完成数百万张扫描结果。这将简化操作流程，并将医疗保健服务扩展到更广泛的人群，从而提昇放射治疗市场的收入。

转向个人化医疗

癌症治疗中个人化医疗的日益兴起也对放射治疗市场产生了重大影响。根据可能影响治疗反应的遗传、表型和环境因素客製化放射剂量和时间表是个人化医疗方法的一部分，旨在根据每位患者的独特特征量身定制医疗方案。透过专注于量身定制的患者护理，医疗保健从业者可以提高治疗效果并减少不良副作用的发生。根据个人化医疗联盟的一项调查，2016 年至 2020 年间，美国市场上的定製药物数量有所增加。这些药物从 132 种增加到 2019 年的 286 种，占 FDA 批准的所有新药的 25%。这比 2005 年的 5% 大幅成长。这种增长正在推高放射治疗市场份额。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球放射治疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 体外放射治疗
    • 关键部分
      • 调强放射治疗（IMRT）
      • 影像导引放射治疗（IGRT）
      • 断层治疗
      • 立体定位放射外科
      • 立体定位放射治疗
      • 质子治疗
      • 3D适形放射治疗（3D CRT）
      • 容积调强弧形治疗 (VMAT)
  • 内部放射治疗/近距离放射治疗
  • 全身放射治疗

第七章：市场区隔：依应用

  • 皮肤和唇癌
  • 头颈癌
  • 乳癌
  • 摄护腺癌
  • 子宫颈癌
  • 肺癌
  • 其他的

第 8 章：市场区隔：依最终用户

  • 医院
  • 癌症研究机构
  • 门诊及放射治疗中心

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Eckert & Ziegler
    • Elekta AB (publ)
    • General Electric Company
    • Hitachi Ltd
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion Inc. (Sotera Health)
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112025A4413

The global radiotherapy market size was valued at USD 7.1 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.9 Billion by 2033, exhibiting a CAGR of 3.8% during 2025-2033. North America currently dominates the market, holding a market share of over 35.8% in 2024. The market is growing due to a variety of factors, including rising cancer incidence, rapid technological improvements, improved tumor targeting accuracy, rising healthcare costs, and increased awareness of the advantages of radiotherapy as a non-invasive cancer treatment alternative.

The growing incidence of cancer is one of the primary factors of the radiotherapy market. Cancer is a growing cause of mortality worldwide, with millions of cases diagnosed each year. It is expected that in 2024, there would be around 2,001,140 new instances of cancer diagnosed in the United States, with 611,720 individuals dying from the same. This growing load raises the need for better treatment options such as radiotherapy. It is a key component of cancer treatment because it can precisely target malignant cells while inflicting minimum harm to healthy tissues. Additionally, the expanding geriatric population contributes to this need, as the risk of cancer grows with age. Aside from this, governments and health care organizations are launching awareness programs and early screening initiatives to detect cancer at treatable stages, which is promoting the use of radiotherapy.

The United States is one market disruptor because of rapid technological advancement, and government expenditure on healthcare. The adoption of non-invasive treatment options also sets it apart. The US market is at the forefront of implementing cutting-edge radiation technology, which has greatly boosted the market growth. Recently, the numerical and geographic expansion of proton treatment facilities, with over 40 operating centers in the United States alone, has resulted in enhanced patient access as well as an exponential increase in the capacity to collect clinical data and complete participation in multicenter clinical studies. Furthermore, the growing healthcare expenditure in the United States, which is expected to expand 7.5% to $4.8 trillion by 2023, is a key driver of radiotherapy growth in the country. Moreover, federal programs like the Cancer Moonshot initiative that work to reduce cancer mortality rates through enhanced research, innovation, and access to care is fueling the market expansion. This increased funding has led to the establishment of specialized cancer centers equipped with state-of-the-art radiotherapy systems.

Radiotherapy Market Trends:

Technological Advancements

Recent advancements and technologies in the radiotherapy industry, such image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT), have increased the accuracy and efficacy of cancer treatments, which has aided in the market growth. IGRT involves the use of real-time imaging in order to ensure that the tumor is precisely targeted during radiation therapy sessions even in cases when there is movement between treatments. This enables doctors to adjust the radiation dosage by adjusting the beam intensity during therapy, thereby fitting the radiation dose to the shape of the tumor while reducing exposure to adjacent healthy tissues. Additionally, the IAEA launched a research in April 2020 to investigate how Stereotactic Fractionated Radiotherapy (SFRT) might improve palliative care for cervical and lung malignancies with the goal of reducing symptoms and delaying the course of the disease, which is assisting in boosting the market growth. With Europe's most comprehensive technical radiotherapy platform, Institut Curie is France's leading proton therapy center. In 2023, Institut Curie planned to launch a broad-ranging radiotherapy program involving a major investment plan to boost the modernization of its technical platform and offer its patients the most innovative and groundbreaking techniques. This major plan involves 56 million euros (USD 58.98 Million) invested over 6 years, covering all radiotherapy equipment and all Institut Curie sites: Paris, Saint-Cloud and Orsay.

Integration of Artificial Intelligence (AI) in Radiotherapy

AI technologies are being used to streamline the planning process, improve the accuracy of radiation dosing, and optimize treatment schedules. Machine learning (ML) algorithms can analyse large datasets of imaging and treatment records to identify patterns and predict optimal treatment approaches tailored to individual patients. AI is also being utilized to develop predictive models for patient responses to various radiation therapies, which can be used in adaptive radiotherapy to adjust treatments based on the patient's response to ongoing sessions. Radiologists look at approximately 225,000 MRI/CT exams in 40 years, while AI can start with 225,000 scans to train itself and reach millions of scans within a very short period of time. This will streamline operations and expand healthcare services to a larger population, thereby boosting radiotherapy market revenue.

Shift Toward Personalized Medicine

The market for radiotherapy is also majorly impacted by the increasing movement toward individualized medicine in cancer treatment. Customizing radiation doses and schedules based on genetic, phenotypic, and environmental factors that may impact treatment response is a component of personalized medicine approaches, which aim to tailor medical treatment to each patient's unique characteristics. By focusing on tailored patient care, healthcare practitioners can boost treatment efficacy and decrease the occurrence of adverse side effects. According to a survey by the Personalized Medicine Coalition, the number of customized medications available in the US market grew between 2016 and 2020. These medications increased from 132 to 286 in 2019, making up 25% of all new pharmaceuticals authorized by the FDA. This is a substantial increase from 5% in 2005. This growth is boosting the radiotherapy market share.

Radiotherapy Industry Segmentation:

Analysis by Type:

  • External Beam Radiation Therapy
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Image-Guided Radiation Therapy (IGRT)
    • Tomotherapy
    • Stereotactic Radiosurgery
    • Stereotactic Body Radiation Therapy
    • Proton Therapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy/Brachytherapy
  • Systemic Radiation Therapy

External beam radiation therapy leads the market with around 62.0% of market share in 2024. According to radiotherapy industry market research, the increasing demand for external beam radiation treatment (EBRT) is fueled by its adaptability and efficiency in precisely treating a variety of tumors. Accordingly, EBRT continues to be the most widely used type of radiotherapy because it can precisely target tumors with high-energy beams while causing the least amount of harm to nearby healthy tissues. Additionally, the introduction of technologically sophisticated systems such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and three-dimensional (3D) conformal radiation therapy has greatly boosted the appeal of EBRT and created a favorable outlook for market expansion.

Analysis by Application:

  • Skin and Lip Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Breast cancer lead the market with around 28.8% of market share in 2024. Radiotherapy's efficacy as a standard post-operative therapeutic strategy to prevent tumor recurrence in breast cancer represents a crucial factor driving its market demand. According to the World Health Organization (WHO), there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally in 2022. This increasing incidence of breast cancer globally necessitates effective treatment modalities, and radiotherapy is recognized for its critical role in the early and advanced stages of the disease. It is particularly effective in conserving the breast in cases of early-stage breast cancer, often used following lumpectomy to eliminate any remaining cancerous cells and significantly reduce the risk of cancer returning. Additionally, radiotherapy also helps alleviate symptoms and control tumor growth in advanced metastatic cases, which is further boosting its demand.

Analysis by End User:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

As per the radiotherapy market report, its demand in ambulatory and radiotherapy centers is driven by an increasing preference for outpatient care settings, which offer cost-efficiency, convenience, and reduced patient burden compared to in-hospital treatments. Ambulatory care centers are particularly appealing because they enable patients to receive high-quality, specialized care without the need for overnight hospital stays. Additionally, these centers can often provide services at a lower cost than traditional hospital settings due to their specialized nature and efficiency in managing specific treatments like radiotherapy. This cost-effectiveness attracts patients and healthcare payers seeking to manage expenditures. Furthermore, the proliferation of radiotherapy centers and technological advancements that make sophisticated radiotherapy equipment more compact and affordable, are propelling the market forward.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 35.8%. The demand for radiotherapy in North America is propelled by numerous factors such as well-established healthcare infrastructure, robust funding for cancer research, and the high prevalence of cancer. North America boosts some of the world's leading cancer research facilities and hospitals, which adopt and also develop cutting-edge radiotherapy technologies. In addition to this, the region benefits from substantial healthcare spending both from the public and private sectors, allowing for significant investments in advanced medical equipment and treatment modalities. Furthermore, there is a strong focus on early cancer detection and screening programs, which identify patients who can benefit from early intervention using radiotherapy, which is impelling the market growth.

Key Regional Takeaways:

United States Radiotherapy Market Analysis

In North America, the United States held a market share of over 85.00% in 2024. High cancer incidence rates and improvements in treatment technology exerted an impact on the U.S. radiotherapy market. The American Cancer Society estimates that more than 1.9 million new cases of cancer were recorded in 2023. Additionally, the national health spending is projected to rise from USD 4.8 trillion in 2023 to USD 7.7 trillion by 2032, according to the Centers for Medicare & Medicaid Services (CMS). In actuality, this highlights the pressing need for sophisticated and affordable therapies like radiotherapy. The adoption of novel radiation treatments is being further accelerated by initiatives such as the National Cancer Moonshot, which aims to double the rate of improvements in cancer research and treatment. Repute players like Varian and Elekta are introducing AI-powered radiotherapy systems, which would help improve accuracy and patient outcomes. The actual utilization of proton therapy centers saw a rise of 30% in the period between 2020 and 2023, reflecting the growing demand for specialized cancer treatments in the region.

Europe Radiotherapy Market Analysis

Europe's radiotherapy market is strewn with a mighty emphasis on cancer care and sizeable government funding for innovation in healthcare. Cancer remains the second cause of death in Europe with approximately 2.7 million new cases every year. The European Union has allocated USD 5.31 Billion to health programs under Horizon Europe for 2021-2027. Such funds are bound to nudge acceptance of advanced radiotherapy equipment. The leading nations are Germany, France, and the UK, investing significant amounts in proton therapy and stereotactic radiotherapy technologies. The acceleration in this market has been further driven by a surge in non-invasive treatments and the fulfilment of the European Medical Device Regulation (MDR). The ESTRO indicated that in 2014, there were more than 2,192 linear accelerators across 27 European countries, with a significant increase in modern linear accelerators in recent years. By 2023, more than 75% of radiation oncology centers in Europe used modern linacs and ensured better patient access to precision therapy.

Asia Pacific Radiotherapy Market Analysis

Asia Pacific is one of the fastest-growing regions in terms of radiotherapy due to incidence of cancer, improved healthcare infrastructure, and growing awareness. Government initiatives, such as India's National Cancer Grid and China's Healthy China 2030 plan, form the very basis of the increasing adoption of advanced radiotherapy equipment. The region also sees massive private investment, with Japan and South Korea always at the forefront of their own research in proton therapy. According to an industrial report, China saw a 40% increase in installations of linear accelerators from 2018 to 2023. In India, oncology centers continue to adopt brachytherapy solutions at a rapid pace. Collaborative projects, such as Elekta's training programs for radiotherapists in the region, are tackling the shortage of skilled workforce to make such treatments more widely accessible.

Latin America Radiotherapy Market Analysis

The radiotherapy market in Latin America is expanding due to rising cancer rates and efforts to improve access to healthcare in the region. Brazil and Mexico capture the largest market share, with an increasing number of radiotherapy installations in public and private hospitals. In August 2024, Elekta (a Swedish Company) received a USD 64 Million order for advanced linear accelerators and the Elekta Esprit Gamma Knife from Mexico's Hospital Angeles Health System. This reflects the country's increased efforts to improve cancer care across the nation. Medical tourism in Costa Rica and Colombia is also on the rise, and clinics have taken up state-of-the-art systems to attract international patients. Such development indicates that the region is committed to managing their carcinogenic burdens effectively.

Middle East and Africa Radiotherapy Market Analysis

The radiotherapy market in Middle East and Africa is on the growth trajectory based on government initiatives and private investments in healthcare. The International Agency for Research on Cancer (IARC) reports that the African region recorded around 1.1 Million new cancer cases in the year 2020, and the burden would continue to grow with population increase and exposure to more risk factors. The Vision 2030 initiative in Saudi Arabia and the National Cancer Strategic Framework 2022-2027 in South Africa are also promoting the adoption of radiotherapy. There is also an effort to increase access by like-minded global firms partnering with local delivery providers; a case in point is the partnership by Elekta to train radiotherapists in sub-Saharan Africa. Rising telemedicine adoption and mobile health platforms further support treatment planning and follow-ups, enhancing patient outcomes.

Competitive Landscape:

The competitive landscape is characterized by the presence of prominent radiotherapy companies who are engaged in fierce competition through technological innovation, mergers, and acquisitions, and expansion into emerging markets. They are developing advanced radiotherapy systems with enhanced precision and adaptability and leveraging their broad technological portfolios and strong global presence to enhance their market share and penetrate new geographical regions. Additionally, specialized companies are focusing on niche technologies like brachytherapy and compact proton therapy systems, respectively to offer tailored solutions that meet specific clinical needs and gain a competitive edge in the market.

The report has provided a comprehensive analysis of the competitive landscape in the radiotherapy market with detailed profiles of all major companies, including:

  • Accuray Incorporated
  • Becton Dickinson and Company
  • Eckert & Ziegler
  • Elekta AB
  • General Electric Company
  • Hitachi Ltd
  • Ion Beam Applications
  • Isoray Inc.
  • Mevion Medical Systems Inc.
  • Nordion Inc. (Sotera Health)
  • Siemens Healthineers AG (Siemens AG)

Key Questions Answered in This Report

  • 1.What is radiotherapy?
  • 2.How big is the radiotherapy market?
  • 3.What is the expected growth rate of the global radiotherapy market during 2025-2033?
  • 4.What are the key factors driving the global radiotherapy market?
  • 5.What is the leading segment of the global radiotherapy market based on the type?
  • 6.What is the leading segment of the global radiotherapy market based on application?
  • 7.What is the leading segment of the global radiotherapy market based on end user?
  • 8.What are the key regions in the global radiotherapy market?
  • 9.Who are the key players/companies in the global radiotherapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiotherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Intensity-Modulated Radiation Therapy (IMRT)
      • 6.1.2.2 Image-Guided Radiation Therapy (IGRT)
      • 6.1.2.3 Tomotherapy
      • 6.1.2.4 Stereotactic Radiosurgery
      • 6.1.2.5 Stereotactic Body Radiation Therapy
      • 6.1.2.6 Proton Therapy
      • 6.1.2.7 3D Conformal Radiotherapy (3D CRT)
      • 6.1.2.8 Volumetric Modulated Arc Therapy (VMAT)
    • 6.1.3 Market Forecast
  • 6.2 Internal Radiation Therapy/Brachytherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Systemic Radiation Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Skin and Lip Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Head and Neck Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Breast Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Prostate Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cervical Cancer
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Lung Cancer
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory and Radiotherapy Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Eckert & Ziegler
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Elekta AB (publ)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hitachi Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Ion Beam Applications
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Isoray Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Mevion Medical Systems Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nordion Inc. (Sotera Health)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Radiotherapy Market: Major Drivers and Challenges
  • Figure 2: Global: Radiotherapy Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Radiotherapy Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Radiotherapy Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Radiotherapy Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Radiotherapy Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Radiotherapy Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Radiotherapy (External Beam Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Radiotherapy (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Radiotherapy (Systemic Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Radiotherapy (Systemic Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Radiotherapy (Skin and Lip Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Radiotherapy (Skin and Lip Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Radiotherapy (Head and Neck Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Radiotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Radiotherapy (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Radiotherapy (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Radiotherapy (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Radiotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Radiotherapy (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Radiotherapy (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Radiotherapy (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Radiotherapy (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Radiotherapy (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Radiotherapy (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Radiotherapy (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Radiotherapy (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Radiotherapy (Cancer Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Radiotherapy (Cancer Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Radiotherapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Radiotherapy Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Radiotherapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Radiotherapy Industry: SWOT Analysis
  • Figure 84: Global: Radiotherapy Industry: Value Chain Analysis
  • Figure 85: Global: Radiotherapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiotherapy Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Radiotherapy Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Radiotherapy Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Radiotherapy Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Radiotherapy Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Radiotherapy Market: Competitive Structure
  • Table 7: Global: Radiotherapy Market: Key Players